Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2207257Generated: November 2, 2026

1-Methylimidazole → Rivaroxaban

https://huagongshe.com/reaction/2207257

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-MethylimidazoleHCID 1390—
ReactantMethanesulfonyl chlorideHCID 31297—
Reactant5-Chloro-2-thiophenecarboxylic acidHCID 95048—
Reactant(S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-oneHCID 11346837—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
ProductRivaroxabanHCID 987540190%

Reaction Steps

1-Methylimidazole (24.6 g, 0.3 mol) was added to a stirred suspension of 5-chlorothiophene-2-carboxylic acid (16.25 g, 0.1 mol) in dichloromethane (162 ml) at 0-5° C. and the resulting solution was stirred for 10 minutes. A solution of methanesulfonyl chloride (12 g, 0.105 mol) in dichloromethane (40 ml) was added to the above solution at −5° C. The resulting solution was stirred for 1 hour at −5° C. to produce a reaction mass containing the sulfonyl ester intermediate, followed by portion wise addition of 4-[4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholine-3-one (29.1 g, 0.1 mol, chiral purity: 99.9%). The reaction mixture was stirred for 2 hours at 25-30° C., followed by the addition of water (162 ml) and then stirring for 15 minutes. The separated solid was filtered, washed with dichloromethane (50 ml) and water (100 ml), and the resulting wet material was dried at 80-85° C. for 3 to 5 hours to produce 39.2 g of pure rivaroxaban as a white crystalline solid (Theoretical Yield: 90%; Purity by HPLC: 99.9%; and Chiral Purity by HPLC: 99.9%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09376427B2
Source datasetuspto-grants-2016_06
ORD IDord-116e4a047b0c4b26a129652425fa91e9
Source noteuspto-grants-2016_06